Concepedia

Nadia Nasser

NN

8

Publications

447

Citations

8

H-Index

2003

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Nadia Nasser is an author at Johnson & Johnson (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2003–2008

8

Publications

8

Identification and Biological Evaluation of 4-(3-Trifluoromethylpyridin-2-yl)piperazine-1-carboxylic Acid (5-Trifluoromethylpyridin-2-yl)amide, a High Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist

Devin M. Swanson, Adrienne E. Dubin, Chandra Shah et al. · Journal of Medicinal Chemistry · 2004 · 183 citations · Full text

, , +17

Pharmacology and Antitussive Efficacy of 4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic Acid (5-Trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a Transient Receptor Potential Vanilloid 1 Antagonist in Guinea Pigs

Anindya Bhattacharya, Brian Scott, Nadia Nasser et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 72 citations

Activation of TRPA1 by Farnesyl Thiosalicylic Acid

Michael P. Maher, Hong Ao, Tue G. Banke et al. · Molecular Pharmacology · 2008 · 70 citations

Identifying Modulators of hERG Channel Activity Using the PatchXpress® Planar Patch Clamp

Adrienne E. Dubin, Nadia Nasser, Jutta Rohrbacher et al. · SLAS DISCOVERY · 2005 · 40 citations · Full text

N-Isoquinolin-5-yl-N′-aralkyl-urea and -amide antagonists of human vanilloid receptor 1

Michele C. Jetter, Mark A. Youngman, James J. McNally et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 22 citations · Full text

, , +6

Rows per page

1–5 of 8